Antihistamines are a common solution for allergy sufferers, but it's crucial to understand their mechanisms, side effects, and potential risks before reaching for them. These medications work by blocking histamine receptors, providing relief from symptoms like swelling, redness, itching, and sneezing. However, they don't address the underlying cause of the allergy.
There are two main types of antihistamines: H1 and H2. H1 antihistamines are the standard choice for hay fever, hives, and skin reactions, while H2 antihistamines are primarily used for acid-related conditions. The key difference lies in their target receptors; H1 antihistamines block receptors in the body, while H2 antihistamines target receptors in the stomach lining.
The first generation of H1 antihistamines, including diphenhydramine (Benadryl), chlorpheniramine, and hydroxyzine, are effective but come with a trade-off. They cross the blood-brain barrier, leading to significant drowsiness, impaired concentration, and anticholinergic effects. These side effects can be particularly problematic for older adults, increasing the risk of falls and sharp drops in blood pressure. The second generation of H1 antihistamines, such as loratadine (Claritin), cetirizine (Zyrtec), and fexofenadine (Allegra), were developed to limit blood-brain barrier penetration, resulting in reduced sedative effects and lower anticholinergic qualities.
A 2024 study raised concerns about the potential link between H1 antihistamines and dementia. The research found an elevated dementia risk associated with cumulative exposure to both generations of H1 antihistamines, with a higher risk in the first generation group. However, this finding sparked debate among clinicians, as residual factors like smoking, physical activity, and underlying disease severity could not be fully controlled. A 2025 commentary further questioned the study's findings, highlighting the need for closer scrutiny and the potential influence of other variables.
Additionally, a 2025 analysis linked first-generation antihistamine prescriptions to an increased risk of delirium in older hospitalized patients, reflecting the known impact of these drugs on vulnerable brains. While the current evidence doesn't prove a direct cause-and-effect relationship between antihistamines and dementia, it underscores the risks associated with long-term use of first-generation antihistamines.
It's essential to exercise caution when using first-generation H1 antihistamines, especially in individuals over 65. These medications are contraindicated in people with enlarged prostates, urinary retention, angle-closure glaucoma, and certain heart rhythm disorders. Driving or operating machinery after taking them is highly inadvisable. Second-generation options are generally safer, but people with severe kidney impairment may require adjusted dosages.
During pregnancy, particularly in the first trimester, avoiding systemic allergy drugs is considered the safest approach. Clinicians often recommend managing prenatal allergy symptoms with non-pharmacological methods, such as saline nasal rinses, before considering over-the-counter medications.
While natural alternatives like quercetin, green tea, and nettle extract show some cellular evidence of antihistamine-like effects, they are unlikely to replace standard medications for moderate to severe reactions. Anyone experiencing persistent allergy symptoms for more than 48 hours should consult a healthcare provider for proper evaluation and treatment.
